Selicrelumab
Selicrelumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Selicrelumab is under investigation in clinical trial NCT01008527 (Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100).
| Trade Name | Selicrelumab |
| Generic | Selicrelumab |
| Selicrelumab Other Names | CP 870,893, Selicrelumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Selicrelumab
